Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Binnopharm Group
Moscow, Moscow Region, Russia
- Ownership
- Private
- Employees
- ~233
- Development stage
- Other
01
Overview
Binnopharm Group is a top 3 Russian pharmaceutical company with one of the largest drug portfolios in Russia, manufacturing over 240 medicines on the national List of Vital and Essential Medicines. It is fully commercial with a wide range of generic and branded drugs, including biotech and original drugs, actively supplying hospitals and retail and exporting to over 14 countries.[1][2][3][4]
- Therapeutic areas
- EndocrinologyInfectious DiseasesCardiovascularOtherNeurology
- Modalities
- Small moleculeBiologicVaccineRecombinant protein
- Industry
- Biotech
02
Partnerships
Dr. Reddy's (acquisition of antibacterial brands)
Beyond the preview
Go deeper on Binnopharm Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Binnopharm Group.